GB0420250D0 - Method for oral drug delivery - Google Patents

Method for oral drug delivery

Info

Publication number
GB0420250D0
GB0420250D0 GB0420250A GB0420250A GB0420250D0 GB 0420250 D0 GB0420250 D0 GB 0420250D0 GB 0420250 A GB0420250 A GB 0420250A GB 0420250 A GB0420250 A GB 0420250A GB 0420250 D0 GB0420250 D0 GB 0420250D0
Authority
GB
United Kingdom
Prior art keywords
drug delivery
oral drug
oral
delivery
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB0420250A
Other versions
GB2417900A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MEDWAY SCIENCE TECHNOLOGIES LT
Original Assignee
MEDWAY SCIENCE TECHNOLOGIES LT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MEDWAY SCIENCE TECHNOLOGIES LT filed Critical MEDWAY SCIENCE TECHNOLOGIES LT
Priority to GB0420250A priority Critical patent/GB2417900A/en
Publication of GB0420250D0 publication Critical patent/GB0420250D0/en
Publication of GB2417900A publication Critical patent/GB2417900A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
GB0420250A 2004-09-11 2004-09-11 Composition for oral drug delivery Withdrawn GB2417900A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0420250A GB2417900A (en) 2004-09-11 2004-09-11 Composition for oral drug delivery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0420250A GB2417900A (en) 2004-09-11 2004-09-11 Composition for oral drug delivery

Publications (2)

Publication Number Publication Date
GB0420250D0 true GB0420250D0 (en) 2004-10-13
GB2417900A GB2417900A (en) 2006-03-15

Family

ID=33186906

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0420250A Withdrawn GB2417900A (en) 2004-09-11 2004-09-11 Composition for oral drug delivery

Country Status (1)

Country Link
GB (1) GB2417900A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160033796A (en) 2006-03-28 2016-03-28 자블린 파머슈티칼스 인코포레이티드 Formulations of low dose diclofenac and beta-cyclodextrin
EP4137142A1 (en) * 2013-03-14 2023-02-22 Purple Mundo, Inc. Bioactive concentrates and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340614A (en) * 1993-02-11 1994-08-23 Minnesota Mining And Manufacturing Company Methods of polymer impregnation
IT1296464B1 (en) * 1997-11-19 1999-06-25 Vectorpharma Int PHARMACEUTICAL COMPOSITIONS IN THE FORM OF DRUG-LOADED CROSS-LINKED POLYMER POWDERS AND RELATED PREPARATION PROCESS BY MEANS
DK1515699T3 (en) * 2002-03-07 2009-05-04 Eurand Pharmaceuticals Ltd Process for charge and thermodynamic activation of drugs on polymers by supercritical fluids

Also Published As

Publication number Publication date
GB2417900A (en) 2006-03-15

Similar Documents

Publication Publication Date Title
HK1252167A1 (en) Liposomes useful for drug delivery
HK1248521A1 (en) Oral therapeutic compound delivery system
EP1750674A4 (en) Microparticles for oral delivery
IL174748A0 (en) Nanoparticles for drug delivery
GB0402131D0 (en) Delivery method
EP1824410A4 (en) Systems and methods for intra-oral drug delivery
PL3437682T3 (en) Drug delivery device
EP1750677A4 (en) Oral therapeutic compound delivery system
EG24701A (en) Cap for drug delivery devices
IL184552A (en) Apparatus for medicament delivery
EP1648327A4 (en) Oral devices and methods for controlled drug delivery
PL2322180T3 (en) Diketopiperazine salts for drug delivery
IL174690A0 (en) Enhanced drug delivery
EP1781355A4 (en) Drug delivery device
EP1802258A4 (en) Biosynchronous transdermal drug delivery
EP1757273A4 (en) Preparation for oral administration
IL174396A0 (en) Oral drug delivery system
EP1761250A4 (en) Oral delivery system
EP1858493A4 (en) Oral drug delivery system
GB0420250D0 (en) Method for oral drug delivery
PL373776A1 (en) Oral pharmaceutical compound
GB0401008D0 (en) Drug delivery system
IL185561A0 (en) Microject devices and methods for drug delivery
TWI340043B (en) Oral drug delivery system
GB0409506D0 (en) Drug delivery

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)